BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 21727693)

  • 1. Evidence-based treatments for pemphigus vulgaris, pemphigus foliaceus, and bullous pemphigoid: a systematic review.
    Singh S
    Indian J Dermatol Venereol Leprol; 2011; 77(4):456-69. PubMed ID: 21727693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid.
    Eming R; Sticherling M; Hofmann SC; Hunzelmann N; Kern JS; Kramer H; Pfeiffer C; Schuster V; Zillikens D; Goebeler M; Hertl M; Nast A; Orzechowski HD; Sárdy M; Schmidt E; Sitaru C; Sporbeck B; Worm M
    J Dtsch Dermatol Ges; 2015 Aug; 13(8):833-44. PubMed ID: 26213827
    [No Abstract]   [Full Text] [Related]  

  • 3. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
    Sami N; Ahmed AR
    Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy.
    Buonavoglia A; Leone P; Dammacco R; Di Lernia G; Petruzzi M; Bonamonte D; Vacca A; Racanelli V; Dammacco F
    Autoimmun Rev; 2019 Apr; 18(4):349-358. PubMed ID: 30738958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bullous autoimmune diseases of the oral mucosa].
    Vaillant L
    Rev Stomatol Chir Maxillofac; 1999 Oct; 100(5):230-9. PubMed ID: 10604215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World Workshop of Oral Medicine VII: A systematic review of immunobiologic therapy for oral manifestations of pemphigoid and pemphigus.
    Mays JW; Carey BP; Posey R; Gueiros LA; France K; Setterfield J; Woo SB; Sollecito TP; Culton D; Payne AS; Greenberg MS; De Rossi S
    Oral Dis; 2019 Jun; 25 Suppl 1(Suppl 1):111-121. PubMed ID: 31140696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients.
    Beckers RC; Brand A; Vermeer BJ; Boom BW
    Br J Dermatol; 1995 Aug; 133(2):289-93. PubMed ID: 7547400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune bullous skin diseases. Part 1: Clinical manifestations.
    Kneisel A; Hertl M
    J Dtsch Dermatol Ges; 2011 Oct; 9(10):844-56; quiz 857. PubMed ID: 21955378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
    Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M
    Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune blistering skin diseases.
    Cotell S; Robinson ND; Chan LS
    Am J Emerg Med; 2000 May; 18(3):288-99. PubMed ID: 10830686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune bullous diseases: diagnosis and management.
    McCuin JB; Hanlon T; Mutasim DF
    Dermatol Nurs; 2006 Feb; 18(1):20-5. PubMed ID: 16550892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.
    Gürcan HM; Ahmed AR
    Am J Clin Dermatol; 2009; 10(6):383-96. PubMed ID: 19824739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy for autoimmune bullous diseases.
    Meurer M
    Clin Dermatol; 2012; 30(1):78-83. PubMed ID: 22137230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogeneses of pemphigus and pemphigoid diseases.
    Ujiie H; Yamagami J; Takahashi H; Izumi K; Iwata H; Wang G; Sawamura D; Amagai M; Zillikens D
    J Dermatol Sci; 2021 Dec; 104(3):154-163. PubMed ID: 34916040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Milestones in Personalized Medicine in Pemphigus and Pemphigoid.
    Bieber K; Kridin K; Emtenani S; Boch K; Schmidt E; Ludwig RJ
    Front Immunol; 2020; 11():591971. PubMed ID: 33505392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of bullous pemphigoid: recommendations for immunomodulatory treatments.
    Kirtschig G; Khumalo NP
    Am J Clin Dermatol; 2004; 5(5):319-26. PubMed ID: 15554733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a survey of German dermatologists on the therapeutic approaches to pemphigus and bullous pemphigoid.
    Hofmann SC; Kautz O; Hertl M; Sticherling M; Zillikens D; Bruckner-Tuderman L
    J Dtsch Dermatol Ges; 2009 Mar; 7(3):227-33. PubMed ID: 19371245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Autoimmune Bullous Diseases in Elderly Patients in Iran: A 10-Year Retrospective Study.
    Ghiasi M; Daneshpazhooh M; Ismonov M; Chams-Davatchi C
    Skinmed; 2017; 15(3):175-180. PubMed ID: 28705276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune blistering diseases in the elderly.
    Parker SR; MacKelfresh J
    Clin Dermatol; 2011; 29(1):69-79. PubMed ID: 21146735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis therapy of pemphigus and bullous pemphigoid.
    Roujeau JC
    Semin Dermatol; 1988 Sep; 7(3):195-200. PubMed ID: 3153444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.